Flavonoids and Their Glycosides as Anti-amyloidogenic Compounds: Aβ1-42 Interaction Studies to Gain New Insights into Their Potential for Alzheimer's Disease Prevention and Therapy

The Quest for Small Molecules as Amyloid Inhibiting Therapies for Alzheimer's Disease

(2017) Hozefa Amijee et al.   JOURNAL OF ALZHEIMERS DISEASE

How Epigallocatechin-3-gallate and Tetracycline Interact with the Josephin Domain of Ataxin-3 and Alter Its Aggregation Mode

(2015) Marcella Bonanomi et al.   CHEMISTRY-A EUROPEAN JOURNAL

Structural Modifications ofcis-Glycofused Benzopyran Compounds and Their Influence on the Binding to Amyloid-β Peptide

(2015) Cristina Airoldi et al.   Chemistry-An Asian Journal

Naturally occurring polyphenolic inhibitors of amyloid beta aggregation

(2014) Quentin I. Churches et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Natural Compounds against Neurodegenerative Diseases: Molecular Characterization of the Interaction of Catechins from Green Tea with Aβ1-42, PrP106-126, and Ataxin-3 Oligomers

(2014) Erika Sironi et al.   CHEMISTRY-A EUROPEAN JOURNAL

Nanoliposomes presenting on surface a cis-glycofused benzopyran compound display binding affinity and aggregation inhibition ability towards Amyloid β1-42 peptide

(2014) Cristina Airoldi et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Flavones: An important scaffold for medicinal chemistry

(2014) Manjinder Singh et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Exploiting the Therapeutic Potential of 8-β-d-Glucopyranosylgenistein: Synthesis, Antidiabetic Activity, and Molecular Interaction with Islet Amyloid Polypeptide and Amyloid β-Peptide (1–42)

(2014) Ana R. Jesus et al.   JOURNAL OF MEDICINAL CHEMISTRY

Cis-Glyco-Fused Benzopyran Derivatives as Hit Compounds for the Development of Therapeutic and Diagnostic Tools against Neurodegenerative Diseases

(2014) Silvia Merlo et al.   ChemPlusChem

Flavonoids as Therapeutic Compounds Targeting Key Proteins Involved in Alzheimer’s Disease

(2013) Filipa I. Baptista et al.   ACS Chemical Neuroscience

Natural Compounds against Alzheimer’s Disease: Molecular Recognition of Aβ1-42 Peptide bySalvia sclareoidesExtract and its Major Component, Rosmarinic Acid, as Investigated by NMR

(2013) Cristina Airoldi et al.   Chemistry-An Asian Journal

Flavonoid Bioavailability and Attempts for Bioavailability Enhancement

(2013) Surangi Thilakarathna et al.   Nutrients

Polyphenolic Glycosides and Aglycones Utilize Opposing Pathways To Selectively Remodel and Inactivate Toxic Oligomers of Amyloid β

(2011) Ali Reza A. Ladiwala et al.   CHEMBIOCHEM

cis-Glyco-fused benzopyran compounds as new amyloid-β peptide ligands

(2011) Cristina Airoldi et al.   CHEMICAL COMMUNICATIONS

Insights into molecular recognition of LewisX mimics by DC-SIGN using NMR and molecular modelling

(2011) Cinzia Guzzi et al.   ORGANIC & BIOMOLECULAR CHEMISTRY

The Molecular Assembly of Amyloid Aβ Controls Its Neurotoxicity and Binding to Cellular Proteins

(2011) Claudia Manzoni et al.   PLoS One

Beta Amyloid Aggregation Inhibitors: Small Molecules as Candidate Drugs for Therapy of Alzheimers Disease

(2010) F. Re et al.   CURRENT MEDICINAL CHEMISTRY

Tetracycline prevents Aβ oligomer toxicity through an atypical supramolecular interaction

(2010) Cristina Airoldi et al.   ORGANIC & BIOMOLECULAR CHEMISTRY

Targeting Bacterial Membranes: NMR Spectroscopy Characterization of Substrate Recognition and Binding Requirements of D-Arabinose-5-Phosphate Isomerase

(2009) Cristina Airoldi et al.   CHEMISTRY-A EUROPEAN JOURNAL

Glycosylation of Dietary Flavonoids Decreases the Affinities for Plasma Protein

(2009) Jianbo Xiao et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Structure-neurotoxicity relationships of amyloid  -protein oligomers

(2009) K. Ono et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Structural Classification of Toxic Amyloid Oligomers

(2008) Charles G. Glabe   JOURNAL OF BIOLOGICAL CHEMISTRY